← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Enable Biosciences, Inc.
South San Francisco, CA
$8,070,282
Total funding
6
Grants
Funding over time
peak $1.7M · FY2016–25$2M$1.5M$1M$500K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,070,282 · 6
By mechanism
R44$7,397,053 · 3
R43$673,229 · 3
Investigators at Enable Biosciences, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Advancing an accessible, high-throughput and multiplex islet autoantibody test with self-collected capillary dried blood spots for regulatory clearance$990,010
R44 · FY2023 · DK
Advancing an accessible, high-throughput and multiplex islet autoantibody test with self-collected capillary dried blood spots for regulatory clearance$968,473
R44 · FY2024 · DK
Advancing an accessible, high-throughput and multiplex islet autoantibody test with self-collected capillary dried blood spots for regulatory clearance$960,753
R44 · FY2025 · DK
Multiplex food allergy diagnostic based on IgE immunologic markers$845,777
R44 · FY2020 · AI
An Ultrasensitive, High-Throughput, and Low-Cost Autoimmunity Panel for the Early Diagnosis and Improved Treatment of Type 1 Diabetes$749,838
R44 · FY2019 · DK
An Ultrasensitive, High-Throughput, and Low-Cost Autoimmunity Panel for the Early Diagnosis and Improved Treatment of Type 1 Diabetes$749,838
R44 · FY2018 · DK
Development of An Automated High-Throughput Dried Blood Spot Assay to Facilitate Large Scale Screening for Type 1 Diabetes Risk$746,584
R44 · FY2019 · DK
Development of An Automated High-Throughput Dried Blood Spot Assay to Facilitate Large Scale Screening for Type 1 Diabetes Risk$741,180
R44 · FY2020 · DK
Multiplex food allergy diagnostic based on IgE immunologic markers$644,600
R44 · FY2021 · AI
Early and accurate differential diagnosis of Lyme and other tick-borne diseases by agglutination-PCR$225,000
R43 · FY2019 · AI
Antibody-Detection-by-Agglutination-PCR (ADAP): An Ultra-Sensitive, High-Throughput, Multiplexable Tool for T1D Diagnosis and Monitoring$224,423
R43 · FY2016 · DK
Multiplex food allergy diagnostic based on IgE immunologic markers$223,806
R43 · FY2018 · AI